山东新增7家合法网上药店,如意新特大药房在列

2017-01-16 常有才 山东新增7家合法网上药店,如意新特大药房

据山东省食品药品监督管理局官网显示,山东7家公司有望在年前获得《互联网药品交易服务资格证书》,而山东如意新特大药房、济南福仁美大药房等均在列其中。

笔者从山东省食品药品监督管理局官网获悉,山东如意新特大药房有限公司、青岛永鑫医药有限公司、山东建联盛嘉中药有限公司、烟台通御中医世家医药有限公司、济南福仁美大药房连锁有限公司、威海高寿堂医药连锁有限公司、威海市民生缘医药连锁有限公司7家公司,符合国家食品药品监督管理《互联网药品交易服务审批暂行规定》及其补充通知的规定拟予发放《互联网药品交易服务资格证书》,现予以公示,公示期5天,自2017年1月12日至2017年1月16日止。今天是2017年1月16日,是公示日的最后一天,这标志着从明天起,这7家公司所对应的药如意网上药店、青岛永鑫医药网、新华医疗器械、通御中医世家网上药店、山东药房网、高寿堂医药商城、威海市民生缘医药连锁有限公司将成为合法有证的网上药店(网上商城)。前不久,笔者得到知情人士爆料,该消息人士称:山东如意新特大药房要开网上药店,《互联网药品交易服务资格证书》或许会在年后有消息、结果。今天,笔者从山东省食品药品监督管理局官网看到【山东省核发《互联网药品交易服务资格证书》公示(20170112001)】一文,文章透露:包括山东如意新特大药房在内的7家公司有望在年前获得《互联网

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1654279, encodeId=1b4a16542e969, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon May 01 19:06:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085301, encodeId=72422085301fb, content=<a href='/topic/show?id=932643983ec' target=_blank style='color:#2F92EE;'>#大药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43983, encryptionId=932643983ec, topicName=大药房)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Feb 09 05:06:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926658, encodeId=da381926658b9, content=<a href='/topic/show?id=c312e943903' target=_blank style='color:#2F92EE;'>#网上药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79439, encryptionId=c312e943903, topicName=网上药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 09:06:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635041, encodeId=655c1635041b4, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 25 05:06:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345861, encodeId=f0ad134586122, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Wed Jan 18 06:06:00 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-05-01 sunmin0227
  2. [GetPortalCommentsPageByObjectIdResponse(id=1654279, encodeId=1b4a16542e969, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon May 01 19:06:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085301, encodeId=72422085301fb, content=<a href='/topic/show?id=932643983ec' target=_blank style='color:#2F92EE;'>#大药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43983, encryptionId=932643983ec, topicName=大药房)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Feb 09 05:06:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926658, encodeId=da381926658b9, content=<a href='/topic/show?id=c312e943903' target=_blank style='color:#2F92EE;'>#网上药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79439, encryptionId=c312e943903, topicName=网上药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 09:06:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635041, encodeId=655c1635041b4, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 25 05:06:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345861, encodeId=f0ad134586122, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Wed Jan 18 06:06:00 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-02-09 tulenzi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1654279, encodeId=1b4a16542e969, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon May 01 19:06:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085301, encodeId=72422085301fb, content=<a href='/topic/show?id=932643983ec' target=_blank style='color:#2F92EE;'>#大药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43983, encryptionId=932643983ec, topicName=大药房)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Feb 09 05:06:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926658, encodeId=da381926658b9, content=<a href='/topic/show?id=c312e943903' target=_blank style='color:#2F92EE;'>#网上药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79439, encryptionId=c312e943903, topicName=网上药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 09:06:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635041, encodeId=655c1635041b4, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 25 05:06:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345861, encodeId=f0ad134586122, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Wed Jan 18 06:06:00 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1654279, encodeId=1b4a16542e969, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon May 01 19:06:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085301, encodeId=72422085301fb, content=<a href='/topic/show?id=932643983ec' target=_blank style='color:#2F92EE;'>#大药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43983, encryptionId=932643983ec, topicName=大药房)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Feb 09 05:06:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926658, encodeId=da381926658b9, content=<a href='/topic/show?id=c312e943903' target=_blank style='color:#2F92EE;'>#网上药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79439, encryptionId=c312e943903, topicName=网上药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 09:06:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635041, encodeId=655c1635041b4, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 25 05:06:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345861, encodeId=f0ad134586122, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Wed Jan 18 06:06:00 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-25 heli0118
  5. [GetPortalCommentsPageByObjectIdResponse(id=1654279, encodeId=1b4a16542e969, content=<a href='/topic/show?id=33248e580a8' target=_blank style='color:#2F92EE;'>#药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87580, encryptionId=33248e580a8, topicName=药房)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=878524492877, createdName=sunmin0227, createdTime=Mon May 01 19:06:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085301, encodeId=72422085301fb, content=<a href='/topic/show?id=932643983ec' target=_blank style='color:#2F92EE;'>#大药房#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43983, encryptionId=932643983ec, topicName=大药房)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Feb 09 05:06:00 CST 2017, time=2017-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1926658, encodeId=da381926658b9, content=<a href='/topic/show?id=c312e943903' target=_blank style='color:#2F92EE;'>#网上药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79439, encryptionId=c312e943903, topicName=网上药店)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue May 30 09:06:00 CST 2017, time=2017-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635041, encodeId=655c1635041b4, content=<a href='/topic/show?id=a262200e41b' target=_blank style='color:#2F92EE;'>#上药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20074, encryptionId=a262200e41b, topicName=上药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 25 05:06:00 CST 2017, time=2017-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345861, encodeId=f0ad134586122, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Wed Jan 18 06:06:00 CST 2017, time=2017-01-18, status=1, ipAttribution=)]

相关资讯

有时候人之所以痛苦,是因为不肯认命

人,有时候,不妨好好认清自己,不要好高骛远、眼高手低,做个踏踏实实的、认命的人!

鼎臣咨询:化学药、普药向生物制药转型模式分析

生物制药是一个投资金额大、周期长、研发风险高的行业。现在很多化学药、普药企业纷纷向生物制药企业转型,或者强化生物制药的业务单元,转型或强化的同时都需要明确生物制药业务单元的种种风险。

鼎臣咨询:这样做药品营销,医生才不会拒绝你

为医生诊断疾病提供用药解决方案才是医药营销的初衷。

国务院发布《改革规划》,药品电子监管码或将重启

笔者从国务院刚刚印发的《“十三五”深化医药卫生体制改革规划》中发现信息,药品电子监管码或将重启,或者会有新的追溯机制来替代药品电子监管码,最晚将在2020年实现。

针对消费者的用药解决方案是未来药企的关键竞争点

随着中国医药行业竞争态势的发展和全球医药创新的发展,制药企业向服务化转型成为必须

国务院发布《改革规划》,药品电子监管码或将重启

笔者从国务院刚刚印发的《“十三五”深化医药卫生体制改革规划》中发现信息,药品电子监管码或将重启,或者会有新的追溯机制来替代药品电子监管码,最晚将在2020年实现。